Jeremy M. Shaver
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jeremy M. Shaver has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
Barry M. Wise
Eigenvector Research, Inc. Wenatchee WA USA
5 shared publicationsWillem Windig
4 shared publicationsLinda B. McGown
Department of Chemistry, P. M. Gross Chemical Laboratory, Duke University, Box 90346, Durham, North Carolina 27708-0346
3 shared publications- Linda B. McGown
Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY, USA
3 shared publications Michael D. Morris
Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109-1055
3 shared publicationsNeal B. Gallagher
3 shared publications
Latest Publications
- 15 September 2026
- Published by Wiley in Biotechnology Progress
BioOps : Enabling MLOps for scalable and flexible model‐centric process control in biopharmaceutical development
The deployment of advanced modeling and machine learning in biopharmaceutical process control has been limited by legacy fragmented automation infrastructure and a lack of model lifecycle governance. We present BioOps, a modular automation framework for biopharmaceutical advanced process control (APC). The framework incorporates established Machine Learning Operations (MLOps) principles, including version‐controlled model registries, containerized deployment, and continuous integration/continuous delivery (CI/CD) pipelines. BioOps explicitly decouples model development from model execution within the control architecture. This decoupling enables process scientists to deploy, test, and iteratively refine mathematical models and control strategies in a flexible manner. These workflows can be applied across heterogeneous bioreactor platforms and are executed entirely in‐house, without reliance on vendor‐specific solutions or custom system integration. In addition, BioOps embeds traceability, auditability, and model lifecycle management directly into the control stack. As a result, the framework aligns with regulatory expectations while continuing to support agile, in‐house experimentation and development. Case studies across a geographically distributed set of bioreactors demonstrate BioOps' versatility in PAT‐driven feedback control, hybrid model‐based nutrient and glucose feeding, adaptive phase transitions, and cross‐scale deployment. By operationalizing model‐centric control through an MLOps‐inspired architecture, BioOps provides a practical foundation for scalable, reproducible, and future‐ready biomanufacturing.
- 15 September 2026
- Published by Wiley in Biotechnology Progress
BioOps : Enabling MLOps for scalable and flexible model‐centric process control in biopharmaceutical development
The deployment of advanced modeling and machine learning in biopharmaceutical process control has been limited by legacy fragmented automation infrastructure and a lack of model lifecycle governance. We present BioOps, a modular automation framework for biopharmaceutical advanced process control (APC). The framework incorporates established Machine Learning Operations (MLOps) principles, including version‐controlled model registries, containerized deployment, and continuous integration/continuous delivery (CI/CD) pipelines. BioOps explicitly decouples model development from model execution within the control architecture. This decoupling enables process scientists to deploy, test, and iteratively refine mathematical models and control strategies in a flexible manner. These workflows can be applied across heterogeneous bioreactor platforms and are executed entirely in‐house, without reliance on vendor‐specific solutions or custom system integration. In addition, BioOps embeds traceability, auditability, and model lifecycle management directly into the control stack. As a result, the framework aligns with regulatory expectations while continuing to support agile, in‐house experimentation and development. Case studies across a geographically distributed set of bioreactors demonstrate BioOps' versatility in PAT‐driven feedback control, hybrid model‐based nutrient and glucose feeding, adaptive phase transitions, and cross‐scale deployment. By operationalizing model‐centric control through an MLOps‐inspired architecture, BioOps provides a practical foundation for scalable, reproducible, and future‐ready biomanufacturing.
- Open Access
Survey of Chemical Unfolding Complexity as a Unique Stability Assessment Assay for Monoclonal Antibodies
Seventy-two intentionally sequence-diverse antibody variable regions were selected, expressed as IgG1 antibodies, and evaluated by chemical unfolding to survey the complexities of denaturant induced unfolding behavior. A two-transition fit well described the curves and uncovered a wide range of sensitivities to denaturant. Four general types of unfolding curves were observed: balanced traces (each transition responsible for half of the total unfolding transition), low-unfolding traces (first transition is a majority of the unfolding curve), high-unfolding traces (the second transition is the majority of the unfolding curve), and coincident traces (the two transitions are found close to each other, approximating a single transition).The complexity of the data from this survey indicates that focusing on the first inflection point or fitting a single transition model is likely an over-simplistic method for measuring stability by the chemical unfolding assay. Additionally, other conformational assays, such as thermal and low pH unfolding, showed no correlation with the chemical unfolding results, indicating that each of these assays provide alternate information on the different pathways of antibody conformational stability. These results provide a basis for beginning to better connect unfolding behavior to other physical phenotypic behaviors and production process behaviors.
Open AccessSurvey of Chemical Unfolding Complexity as a Unique Stability Assessment Assay for Monoclonal Antibodies
Seventy-two intentionally sequence-diverse antibody variable regions were selected, expressed as IgG1 antibodies, and evaluated by chemical unfolding to survey the complexities of denaturant induced unfolding behavior. A two-transition fit well described the curves and uncovered a wide range of sensitivities to denaturant. Four general types of unfolding curves were observed: balanced traces (each transition responsible for half of the total unfolding transition), low-unfolding traces (first transition is a majority of the unfolding curve), high-unfolding traces (the second transition is the majority of the unfolding curve), and coincident traces (the two transitions are found close to each other, approximating a single transition).The complexity of the data from this survey indicates that focusing on the first inflection point or fitting a single transition model is likely an over-simplistic method for measuring stability by the chemical unfolding assay. Additionally, other conformational assays, such as thermal and low pH unfolding, showed no correlation with the chemical unfolding results, indicating that each of these assays provide alternate information on the different pathways of antibody conformational stability. These results provide a basis for beginning to better connect unfolding behavior to other physical phenotypic behaviors and production process behaviors.
- 4 November 2021
- Published by Springer Nature
- Vol. 2390, 433-445
Deep Learning in Therapeutic Antibody Development
Deep learning applied to antibody development is in its adolescence. Low data volumes and biological platform differences make it challenging to develop supervised models that can predict antibody behavior in actual commercial development steps. But successes in modeling general protein behaviors and early antibody models give indications of what is possible for antibodies in general, particularly since antibodies share a common fold. Meanwhile, new methods of data collection and the development of unsupervised and self-supervised deep learning methods like generative models and masked language models give the promise of rich and deep data sets and deep learning architectures for better supervised model development. Together, these move the industry toward improved developability, lower costs, and broader access of biotherapeutics.
- 4 November 2021
- Published by Springer Nature
- Vol. 2390, 433-445
Deep Learning in Therapeutic Antibody Development
Deep learning applied to antibody development is in its adolescence. Low data volumes and biological platform differences make it challenging to develop supervised models that can predict antibody behavior in actual commercial development steps. But successes in modeling general protein behaviors and early antibody models give indications of what is possible for antibodies in general, particularly since antibodies share a common fold. Meanwhile, new methods of data collection and the development of unsupervised and self-supervised deep learning methods like generative models and masked language models give the promise of rich and deep data sets and deep learning architectures for better supervised model development. Together, these move the industry toward improved developability, lower costs, and broader access of biotherapeutics.
- Open Access
- 1 January 2020
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 109 (1) , 532-542
Evaluation of Crystal Zenith Microtiter Plates for High-Throughput Formulation Screening
- 1 January 2020
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 109 (1) , 532-542
Open AccessEvaluation of Crystal Zenith Microtiter Plates for High-Throughput Formulation Screening
- Open Access
- 1 January 2020
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 109 (1) , 233-246
Framework Mutations of the 10-1074 bnAb Increase Conformational Stability, Manufacturability, and Stability While Preserving Full Neutralization Activity
- 1 January 2020
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 109 (1) , 233-246
Open AccessFramework Mutations of the 10-1074 bnAb Increase Conformational Stability, Manufacturability, and Stability While Preserving Full Neutralization Activity
- Open Access
- 1 December 2018
- Published by Elsevier in Analytical Biochemistry
- Vol. 563, 1-8
Adapting the chemical unfolding assay for high-throughput protein screening using experimental and spectroscopic corrections
- 1 December 2018
- Published by Elsevier in Analytical Biochemistry
- Vol. 563, 1-8
Open AccessAdapting the chemical unfolding assay for high-throughput protein screening using experimental and spectroscopic corrections
- Open Access
- 3 August 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (8) , e0182351
Muscle oxygenation as an indicator of shock severity in patients with suspected severe sepsis or septic shock
The aim of this pilot study was to evaluate the potential of a new noninvasive optical measurement of muscle oxygenation (MOx) to identify shock severity in patients with suspected sepsis. We enrolled 51 adult patients in the emergency department (ED) who presented with possible sepsis using traditional Systematic Inflammatory Response Syndrome criteria or who triggered a “Code Sepsis.” Noninvasive MOx measurements were made from the first dorsal interosseous muscles of the hand once potential sepsis/septic shock was identified, as soon as possible after admission to the ED. Shock severity was defined by concurrent systolic blood pressure, heart rate, and serum lactate levels. MOx was also measured in a control group of 17 healthy adults. Mean (± SD) MOx in the healthy control group was 91.0 ± 5.5% (n = 17). Patients with mild, moderate, and severe shock had mean MOx values of 79.4 ± 21.2%, 48.6 ± 28.6%, and 42.2 ± 4.7%, respectively. Mean MOx for the mild and moderate shock severity categories were statistically different from healthy controls and from each other based on two-sample t-tests (p < 0.05). We demonstrate that noninvasive measurement of MOx was associated with clinical assessment of shock severity in suspected severe sepsis or septic shock. The ability of MOx to detect even mild septic shock has meaningful implications for emergency care, where decisions about triage and therapy must be made quickly and accurately. Future longitudinal studies may validate these findings and the value of MOx in monitoring patient status as treatment is administered.
- 3 August 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (8) , e0182351
Open AccessMuscle oxygenation as an indicator of shock severity in patients with suspected severe sepsis or septic shock
The aim of this pilot study was to evaluate the potential of a new noninvasive optical measurement of muscle oxygenation (MOx) to identify shock severity in patients with suspected sepsis. We enrolled 51 adult patients in the emergency department (ED) who presented with possible sepsis using traditional Systematic Inflammatory Response Syndrome criteria or who triggered a “Code Sepsis.” Noninvasive MOx measurements were made from the first dorsal interosseous muscles of the hand once potential sepsis/septic shock was identified, as soon as possible after admission to the ED. Shock severity was defined by concurrent systolic blood pressure, heart rate, and serum lactate levels. MOx was also measured in a control group of 17 healthy adults. Mean (± SD) MOx in the healthy control group was 91.0 ± 5.5% (n = 17). Patients with mild, moderate, and severe shock had mean MOx values of 79.4 ± 21.2%, 48.6 ± 28.6%, and 42.2 ± 4.7%, respectively. Mean MOx for the mild and moderate shock severity categories were statistically different from healthy controls and from each other based on two-sample t-tests (p < 0.05). We demonstrate that noninvasive measurement of MOx was associated with clinical assessment of shock severity in suspected severe sepsis or septic shock. The ability of MOx to detect even mild septic shock has meaningful implications for emergency care, where decisions about triage and therapy must be made quickly and accurately. Future longitudinal studies may validate these findings and the value of MOx in monitoring patient status as treatment is administered.
- 16 May 2014
- Published by Wiley in Journal of Chemometrics
- Vol. 28 (8) , 663-671
Decompositions using maximum signal factors
Maximum autocorrelation factors (MAF) and whitened principal components analysis are gaining popularity as tools for exploratory analysis of hyperspectral images. This paper shows that the two approaches are mathematically identical when signal and noise (clutter) are defined similarly. It also shows that the MAF metaphor can be generalized to encompass a wide variety of signal processing objectives referred to generically as maximum signal factors while retaining the interpretability of principal components analysis. A subspace projection approximation of the data prior to decomposition is also introduced, which reduces computational memory requirements. For the hyperspectral images studied, it was demonstrated to bring more signal of interest into the first factor as compared with the approach that did not use the subspace approximation. Also, it is expected to significantly reduce the number of scores images needed to be inspected during exploratory analysis. Copyright © 2014 John Wiley & Sons, Ltd.
- 16 May 2014
- Published by Wiley in Journal of Chemometrics
- Vol. 28 (8) , 663-671
Decompositions using maximum signal factors
Maximum autocorrelation factors (MAF) and whitened principal components analysis are gaining popularity as tools for exploratory analysis of hyperspectral images. This paper shows that the two approaches are mathematically identical when signal and noise (clutter) are defined similarly. It also shows that the MAF metaphor can be generalized to encompass a wide variety of signal processing objectives referred to generically as maximum signal factors while retaining the interpretability of principal components analysis. A subspace projection approximation of the data prior to decomposition is also introduced, which reduces computational memory requirements. For the hyperspectral images studied, it was demonstrated to bring more signal of interest into the first factor as compared with the approach that did not use the subspace approximation. Also, it is expected to significantly reduce the number of scores images needed to be inspected during exploratory analysis. Copyright © 2014 John Wiley & Sons, Ltd.
- 1 June 2013
- Published by Elsevier in Analytica Chimica Acta
- Vol. 785, 27-33
Muscle oxygenation measurement in humans by noninvasive optical spectroscopy and Locally Weighted Regression
- 1 June 2013
- Published by Elsevier in Analytica Chimica Acta
- Vol. 785, 27-33
Muscle oxygenation measurement in humans by noninvasive optical spectroscopy and Locally Weighted Regression
- 1 August 2012
- Published by Elsevier in Chemometrics and Intelligent Laboratory Systems
- Vol. 117, 159-168
Simplification of alternating least squares solutions with contrast enhancement
- 1 August 2012
- Published by Elsevier in Chemometrics and Intelligent Laboratory Systems
- Vol. 117, 159-168
Simplification of alternating least squares solutions with contrast enhancement